Удосконалення лікувальної тактики ведення жінок з ендометріозом

Т. Ф Татарчук; Н. Ф. Захаренко; І. П. Маноляк; В. П. Ковбасій

doi:10.18370/2309-4117.2014.18.24-27

Authors

Т. Ф Татарчук Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine, Ukraine
Н. Ф. Захаренко Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine, Ukraine
І. П. Маноляк Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine, Ukraine
В. П. Ковбасій Medical network «Dobrobut», Kyiv, Ukraine

DOI:

https://doi.org/10.18370/2309-4117.2014.18.24-27

Keywords:

endometriosis, adenomyosis, integral indicator of pathology, Vissane, Adaptol, Noophen

Abstract

It was developed and tested a complex drug therapy of women with endometriosis. Within 6 months of the study’s authors are actively watching the 80 women with adenomyosis, which were divided into two groups. The first group of women (n = 42) administered progestin therapy for 6 months – Vissane (dienogest 2 mg). The second group included 38 patients treated with combined therapy: Vissane (dienogest 2 mg) daily for 6 months, Adaptol (mebicar 500 mg) twice a day and Noophen (phenibutum 250 mg) twice a day for three months.

The results showed a slightly higher clinical efficacy of progestogen therapy (Visan) in combination with non-hormonal drugs (Adptol and Noophen).

Author Biographies

Т. Ф Татарчук, Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine

MD, professor, corresponding member. NAMS of Ukraine, Deputy Director for Research, Head of Endocrine Gynecology

Н. Ф. Захаренко, Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine

MD, chief researcher at the Endocrine Gynecology Department

І. П. Маноляк, Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine

Junior Researcher of the Endocrine Gynecology Department

В. П. Ковбасій, Medical network «Dobrobut», Kyiv

PhD

References

Mashkovskiy M.D. «The medicaments.» Moscow, 1(1993):138.
Babichev V.N. «Neurohormonal regulation of ovarian cycle.» M.: Medical (1984):238.
Al-Jefout M., Dezarnaulds G., Cooper M., Tokushige N. et al. «Diagnosis of endometriosis by detection of nerve fibres in an endometrial biopsy: a double blind study.» Hum Reprod, 24(12)(2009):3019-3024.
Okada H. et al. «The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro.» Mol Hum Reprod,4(7)(2001):341-347.
Sasagawa S., Shimizu Y., Kami H. et al. «Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile.» Steroids, 73(2008): 222-23.
Shimizu Y. et al. «Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrial epithelial cells with suppression of cyclin D1 gene expression.» Mol Hum Reprod,10(15)(2009):693-701.
Tatsum H.i., Kitawaki J.i., Tanaka K.i., Hosoda T., Honjo H. «Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule – 1 and vascular cell adhesion molecule – 1 by endothelial cell as compared with other sytetic progestins.» Maturitas, 42(2002):287-94.
Burlaka O.V., Stebljuk V.V. «Assessment of quality of life as a criterion for the effectiveness of treatment and rehabilitation interventions at reproductive disorders.» Journal of Physiotherapy and Health Resort, 18(1)(2012):75-79.
Shchukina N.A., Buyanova, S.N. «The modern view on the diagnosis and treatment of endometriosis». GBUZ «Moscow Regional Research Institute of Obstetrics and Gynecology,» Ministry of Health, BC. Russian Medical Journal, 14 (2014).